Michael Pennick Selected Research

Lisdexamfetamine Dimesylate

5/2016	Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy.
12/2014	Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug.
1/2014	Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells.
1/2013	Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Pennick Research Topics

Disease

5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2016 - 04/2007
2	Chronic Renal Insufficiency 01/2008 - 06/2007
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2013
1	Headache (Headaches) 04/2007
1	Hyperphosphatemia 07/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2006
1	Neoplasms (Cancer) 08/2003

Drug/Important Bio-Agent (IBA)

4	Lisdexamfetamine Dimesylate FDA Link 05/2016 - 01/2013
4	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2016 - 01/2013
3	ProdrugsIBA 05/2016 - 01/2013
3	lanthanum carbonate (Fosrenol)FDA Link 01/2008 - 07/2006
2	Phosphates (Orthophosphate)IBA 01/2008 - 06/2007
2	Guanfacine (Tenex)FDA LinkGeneric 09/2007 - 04/2007
1	AminopeptidasesIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Delayed-Action PreparationsIBA 09/2007
1	CalciumIBA 06/2007
1	aluminum phosphateIBA 07/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2003
1	Matrix Metalloproteinases (MMPs)IBA 08/2003
1	marimastatIBA 08/2003

Therapy/Procedure

1	Therapeutics 04/2007